CoChat

Metabolic Barriers to T Cell Function in Tumors

Open access
Sugiura, Ayaka, Rathmell, Jeffrey C · 2018 · The Journal of Immunology

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Abstract

The metabolic programs that drive T cell functions are exquisitely sensitive to cell intrinsic and extrinsic factors, allowing T cells to respond in a fine-tuned manner to a variety of immune challenges and conditions. However, many of the factors essential for effector T cell function are perturbed in the tumor microenvironment, where oncogenic mutations drive unrestrained cancer cell growth that leads to excess nutrient consumption, excess waste excretion, and insufficient oxygen delivery. This imposes metabolic constraints on infiltrating cells that result in dysfunction and loss of potential antitumor activity in both naturally occurring as well as tailored T cells introduced as part of immunotherapy. In this review, we highlight the metabolic properties that characterize tumor-infiltrating T cells, the barriers within the metabolic landscape of the tumor microenvironment, and the opportunities and challenges they present in development of new cancer therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1701041

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 89 references

Research works printed but not linked: 3

  1. Michalek RD Gerriets VA Jacobs SR Macintyre AN MacIver NJ Mason EF Sullivan SA Nichols AG Rathmell JC 2011 Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets The Journal of Immunology 186 3299 3303 21317389 PMC3198034
  2. Gerriets VA Kishton RJ Johnson MO Cohen S Siska PJ Nichols AG Warmoes MO de Cubas AA MacIver NJ Locasale JW Turka LA Wells AD Rathmell JC 2016 Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression Nat Immunol 17 1459 1466 27695003 PMC5215903
  3. Frauwirth KA Riley JL Harris MH Parry RV Rathmell JC Plas DR Elstrom RL June CH Thompson CB 2002 The CD28 Signaling Pathway Regulates Glucose Metabolism Immunity 16 769 777 12121659

Cited by

See all 223

Metadata

Authors
Sugiura, A., & Rathmell, J. C.
Affiliations
Vanderbilt-Ingram Cancer Center (US)
Corresponding author
Rathmell, Jeffrey C
Venue
The Journal of Immunology
Published
2018-01
Volume
200
Issue
2
Pages
400-407
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2784164696
Cited by
208
References
89
Citations by year
2026: 22 · 2025: 18 · 2024: 15 · 2023: 30 · 2022: 35 · 2021: 32 · 2020: 29 · 2019: 18 · 2018: 9
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of General Medical Sciences (T32GM007347)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK105550)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
T cell metabolism, tumor microenvironment, tumor-infiltrating T cells, T cell dysfunction, cancer immunotherapy, nutrient consumption, oxygen delivery, oncogenic mutations, cancer therapeutics
MeSH terms
Animals, Energy Metabolism, Humans, Immunotherapy, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Molecular Targeted Therapy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.